(Q34337882)

1 August 2017

1 reference

title

The present and future role of photodynamic therapy in cancer treatment (English)

1 reference

1 August 2017

Stanley B Brown

1

1 reference

1 August 2017

Elizabeth A Brown

series ordinal

2

1 reference

1 August 2017

Ian Walker

series ordinal

3

1 reference

1 August 2017

publication date

1 August 2004

1 reference

Lancet Oncology Commission

1 August 2017

published in

1 reference

1 August 2017

volume

5

1 reference

1 August 2017

issue

8

1 reference

1 August 2017

page(s)

497-508

1 reference

Photodynamic therapy: a clinical reality in the treatment of cancer

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

The role of apoptosis in response to photodynamic therapy: what, where, why, and how.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

How does photodynamic therapy work?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

The effect of tissue and cellular pH on the selective biodistribution of porphyrin-type photochemotherapeutic agents: a volumetric titration study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

1 reference

7 January 2021

Light scattering of human skin: a comparison between zinc (II)-phthalocyanine and photofrin II.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Light dosimetry in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Laser and non-laser light sources for photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Photodynamic therapeutics: basic principles and clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

The history of photodetection and photodynamic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Analysis of photosensitivity in Japanese cancer-bearing patients receiving photodynamic therapy with porfimer sodium (Photofrin).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Therapeutic ratio of photodynamic therapy in the treatment of superficial tumours of skin and subcutaneous tissues in man

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Verteporfin: a milestone in opthalmology and photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Verteporfin for age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Low-density lipoprotein receptors in the uptake of tumour photosensitizers by human and rat transformed fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Nonmelanoma cancers of the skin

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Treatment of squamous cell carcinoma of the lip using Foscan-mediated photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Photodynamic therapy of primary nonmelanomatous skin tumours of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Topical aminolevulinic acid HCl photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Photodynamic therapy for the treatment of nonmelanomatous cutaneous malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

A randomised, double-blind, placebo-controlled trial of photodynamic therapy using 5-aminolaevulinic acid for the treatment of cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Photodynamic therapy of high-grade cervical intraepithelial neoplasia with 5-aminolevulinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Aminolevulinic acid-induced photodynamic therapy: safe and effective ablation of dysplasia in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Photodynamic therapy of vulvar intraepithelial neoplasia III using topically applied 5-aminolevulinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Photodynamic therapy of vulvar intraepithelial neoplasia using 5-aminolevulinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX--a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Photodynamic therapy for Barrett's esophagus: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Long-term results of whole bladder wall photodynamic therapy for carcinoma in situ of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Whole bladder photodynamic therapy with 5-aminolevulinic acid using a white light source

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Treatment of early stage non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Effect of photodynamic therapy on recurrent pituitary adenomas: clinical phase I/II trial--an early report

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Photodynamic therapy for malignant newly diagnosed supratentorial gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Photodynamic therapy of brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

mTHPC-mediated photodynamic diagnosis of malignant brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Clinical outcomes of photodynamic therapy for head-and-neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Comparison of 5-aminolaevulinic acid and porphyrin photosensitization for photodynamic therapy of malignant bronchial stenosis: a clinical pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Acute effects of combined photodynamic therapy and hyperbaric oxygenation in lung cancer--a clinical pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Photodynamic therapy enhanced by hyperbaric oxygen in acute endoluminal palliation of malignant bronchial stenosis (clinical pilot study in 40 patients)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Treatment of primary mucosal head and neck squamous cell carcinoma using photodynamic therapy: results after 25 treated cases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Meta-tetra(hydroxyphenyl)chlorin photodynamic therapy in early-stage squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Preliminary report of photodynamic therapy for intraperitoneal sarcomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Intraperitoneal photodynamic therapy causes a capillary-leak syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Does new photosensitizer improve photodynamic therapy in advanced esophageal carcinoma?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Endoscopic photodynamic therapy for obstructing esophageal cancer: 77 cases over a 2-year period

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Photodynamic therapy in the treatment of lung and oesophageal cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

The place of bronchoscopic photodynamic therapy in advanced unresectable lung cancer: experience of 100 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Is bronchoscopic photodynamic therapy a therapeutic option in lung cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Photodynamic therapy for cancer of the pancreas.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Photodynamic therapy for mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

An update on photodynamic therapy applications

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Intrapleural photodynamic therapy: results of a phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

Designing peptide-based scaffolds as drug delivery vehicles

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

State of the art in the delivery of photosensitizers for photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2804%2901529-3

7 January 2021

10.1016/S1470-2045(04)01529-3

Identifiers

DOI

1 reference

1 August 2017

1 reference